Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

213

HTML

1800

Figures (1-2)

138

Tables (1-1)

107

Sum=2258

Jun 15, 2003 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jun 15, 2003; 9(6): 1208-1211
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1208

Figure 1 Survival curves of patients with HCC treated with TAE and untreated controls.

Figure 2 Cumulative incidence of pulmonary metastasis in patients with HCC treated with TAE or untreated controls.

Citation: Lin SC, Shih SC, Kao CR, Chou SY. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J Gastroenterol 2003; 9(6): 1208-1211
URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1208.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1208